Global Ophthalmology Disorders Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Ophthalmology Disorders Drug Market Overview

• 1.1 Product Overview and Scope of Ophthalmology Disorders Drug
• 1.2 Classification of Ophthalmology Disorders Drug by Types
  • 1.2.1 Global Ophthalmology Disorders Drug Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Ophthalmology Disorders Drug Revenue Market Share by Types in 2018
  • 1.2.3 Oral
  • 1.2.4 Injection
  • 1.2.5 External Use
• 1.3 Global Ophthalmology Disorders Drug Market by Application
  • 1.3.1 Global Ophthalmology Disorders Drug Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Juvenile Macular Degeneration (Stargardt Disease)
  • 1.3.3 Leber Congenital Amaurosis (LCA)
  • 1.3.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
  • 1.3.5 Usher Syndrome
  • 1.3.6 Retinitis Pigmentosa (Retinitis)
• 1.4 Global Ophthalmology Disorders Drug Market by Regions
  • 1.4.1 Global Ophthalmology Disorders Drug Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Ophthalmology Disorders Drug Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Ophthalmology Disorders Drug Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ophthalmology Disorders Drug Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Ophthalmology Disorders Drug Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ophthalmology Disorders Drug Status and Prospect (2014-2024)
• 1.5 Global Market Size of Ophthalmology Disorders Drug (2014-2024)

2 Company Profiles

• 2.1 Sanofi
  • 2.1.1 Business Overview
  • 2.1.2 Ophthalmology Disorders Drug Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Sanofi Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Pfizer
  • 2.2.1 Business Overview
  • 2.2.2 Ophthalmology Disorders Drug Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Pfizer Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Novartis
  • 2.3.1 Business Overview
  • 2.3.2 Ophthalmology Disorders Drug Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Novartis Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bayer
  • 2.4.1 Business Overview
  • 2.4.2 Ophthalmology Disorders Drug Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bayer Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Roche
  • 2.5.1 Business Overview
  • 2.5.2 Ophthalmology Disorders Drug Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Roche Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Bausch + Lomb
  • 2.6.1 Business Overview
  • 2.6.2 Ophthalmology Disorders Drug Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Bausch + Lomb Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Gilead Sciences
  • 2.7.1 Business Overview
  • 2.7.2 Ophthalmology Disorders Drug Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Gilead Sciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Takeda Pharmaceutical
  • 2.8.1 Business Overview
  • 2.8.2 Ophthalmology Disorders Drug Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Takeda Pharmaceutical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Usher Syndrome
  • 2.9.1 Business Overview
  • 2.9.2 Ophthalmology Disorders Drug Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Usher Syndrome Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Allergan
  • 2.10.1 Business Overview
  • 2.10.2 Ophthalmology Disorders Drug Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Allergan Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Amgen Inc
  • 2.11.1 Business Overview
  • 2.11.2 Ophthalmology Disorders Drug Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Amgen Inc Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 ReNeuron
  • 2.12.1 Business Overview
  • 2.12.2 Ophthalmology Disorders Drug Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 ReNeuron Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Kubota Pharmaceutical
  • 2.13.1 Business Overview
  • 2.13.2 Ophthalmology Disorders Drug Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Kubota Pharmaceutical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Ocugen
  • 2.14.1 Business Overview
  • 2.14.2 Ophthalmology Disorders Drug Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Ocugen Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Editas Medicine Inc
  • 2.15.1 Business Overview
  • 2.15.2 Ophthalmology Disorders Drug Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Editas Medicine Inc Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Ferrer Corporate
  • 2.16.1 Business Overview
  • 2.16.2 Ophthalmology Disorders Drug Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Ferrer Corporate Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Alkeus Pharmaceuticals
  • 2.17.1 Business Overview
  • 2.17.2 Ophthalmology Disorders Drug Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Amarantus BioScience
  • 2.18.1 Business Overview
  • 2.18.2 Ophthalmology Disorders Drug Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Amarantus BioScience Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.19 ProQR Therapeutics NV
  • 2.19.1 Business Overview
  • 2.19.2 Ophthalmology Disorders Drug Type and Applications
    • 2.19.2.1 Product A
    • 2.19.2.2 Product B
  • 2.19.3 ProQR Therapeutics NV Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.20 Astellas Pharma
  • 2.20.1 Business Overview
  • 2.20.2 Ophthalmology Disorders Drug Type and Applications
    • 2.20.2.1 Product A
    • 2.20.2.2 Product B
  • 2.20.3 Astellas Pharma Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.21 Stealth BioTherapeutics
  • 2.21.1 Business Overview
  • 2.21.2 Ophthalmology Disorders Drug Type and Applications
    • 2.21.2.1 Product A
    • 2.21.2.2 Product B
  • 2.21.3 Stealth BioTherapeutics Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.22 ReGenX Biosciences
  • 2.22.1 Business Overview
  • 2.22.2 Ophthalmology Disorders Drug Type and Applications
    • 2.22.2.1 Product A
    • 2.22.2.2 Product B
  • 2.22.3 ReGenX Biosciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.23 Acucela
  • 2.23.1 Business Overview
  • 2.23.2 Ophthalmology Disorders Drug Type and Applications
    • 2.23.2.1 Product A
    • 2.23.2.2 Product B
  • 2.23.3 Acucela Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.24 Second Sight Medical
  • 2.24.1 Business Overview
  • 2.24.2 Ophthalmology Disorders Drug Type and Applications
    • 2.24.2.1 Product A
    • 2.24.2.2 Product B
  • 2.24.3 Second Sight Medical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.25 AmpliPhi Biosciences
  • 2.25.1 Business Overview
  • 2.25.2 Ophthalmology Disorders Drug Type and Applications
    • 2.25.2.1 Product A
    • 2.25.2.2 Product B
  • 2.25.3 AmpliPhi Biosciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.26 Okuvision
  • 2.26.1 Business Overview
  • 2.26.2 Ophthalmology Disorders Drug Type and Applications
    • 2.26.2.1 Product A
    • 2.26.2.2 Product B
  • 2.26.3 Okuvision Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.27 Applied Genetic Technologies
  • 2.27.1 Business Overview
  • 2.27.2 Ophthalmology Disorders Drug Type and Applications
    • 2.27.2.1 Product A
    • 2.27.2.2 Product B
  • 2.27.3 Applied Genetic Technologies Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.28 Sucampo Pharmaceuticals
  • 2.28.1 Business Overview
  • 2.28.2 Ophthalmology Disorders Drug Type and Applications
    • 2.28.2.1 Product A
    • 2.28.2.2 Product B
  • 2.28.3 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.29 Sun Pharma Advanced Research Company
  • 2.29.1 Business Overview
  • 2.29.2 Ophthalmology Disorders Drug Type and Applications
    • 2.29.2.1 Product A
    • 2.29.2.2 Product B
  • 2.29.3 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.30 Orphagen Pharmaceuticals
  • 2.30.1 Business Overview
  • 2.30.2 Ophthalmology Disorders Drug Type and Applications
    • 2.30.2.1 Product A
    • 2.30.2.2 Product B
  • 2.30.3 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.31 Biovista
  • 2.31.1 Business Overview
  • 2.31.2 Ophthalmology Disorders Drug Type and Applications
    • 2.31.2.1 Product A
    • 2.31.2.2 Product B
  • 2.31.3 Biovista Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.32 Grupo Ferrer Internacional
  • 2.32.1 Business Overview
  • 2.32.2 Ophthalmology Disorders Drug Type and Applications
    • 2.32.2.1 Product A
    • 2.32.2.2 Product B
  • 2.32.3 Grupo Ferrer Internacional Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.33 Dormant Projects
  • 2.33.1 Business Overview
  • 2.33.2 Ophthalmology Disorders Drug Type and Applications
    • 2.33.2.1 Product A
    • 2.33.2.2 Product B
  • 2.33.3 Dormant Projects Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.34 Spark Therapeutics
  • 2.34.1 Business Overview
  • 2.34.2 Ophthalmology Disorders Drug Type and Applications
    • 2.34.2.1 Product A
    • 2.34.2.2 Product B
  • 2.34.3 Spark Therapeutics Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.35 Caladrius Biosciences
  • 2.35.1 Business Overview
  • 2.35.2 Ophthalmology Disorders Drug Type and Applications
    • 2.35.2.1 Product A
    • 2.35.2.2 Product B
  • 2.35.3 Caladrius Biosciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.36 ID Pharma
  • 2.36.1 Business Overview
  • 2.36.2 Ophthalmology Disorders Drug Type and Applications
    • 2.36.2.1 Product A
    • 2.36.2.2 Product B
  • 2.36.3 ID Pharma Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.37 Asklepios BioPharmaceutical
  • 2.37.1 Business Overview
  • 2.37.2 Ophthalmology Disorders Drug Type and Applications
    • 2.37.2.1 Product A
    • 2.37.2.2 Product B
  • 2.37.3 Asklepios BioPharmaceutical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.38 InFlectis BioScience
  • 2.38.1 Business Overview
  • 2.38.2 Ophthalmology Disorders Drug Type and Applications
    • 2.38.2.1 Product A
    • 2.38.2.2 Product B
  • 2.38.3 InFlectis BioScience Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.39 Dompe Farmaceutici
  • 2.39.1 Business Overview
  • 2.39.2 Ophthalmology Disorders Drug Type and Applications
    • 2.39.2.1 Product A
    • 2.39.2.2 Product B
  • 2.39.3 Dompe Farmaceutici Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.40 Ionis Pharmaceuticals
  • 2.40.1 Business Overview
  • 2.40.2 Ophthalmology Disorders Drug Type and Applications
    • 2.40.2.1 Product A
    • 2.40.2.2 Product B
  • 2.40.3 Ionis Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.41 Mimetogen Pharmaceuticals
• 2.42 Khondrion
• 2.43 SanBio
• 2.44 M's Science
• 2.45 Nanovector
• 2.46 Ixchel Pharma
• 2.47 Mitotech

3 Global Ophthalmology Disorders Drug Market Competition, by Players

• 3.1 Global Ophthalmology Disorders Drug Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Ophthalmology Disorders Drug Players Market Share
  • 3.2.2 Top 10 Ophthalmology Disorders Drug Players Market Share
• 3.3 Market Competition Trend

4 Global Ophthalmology Disorders Drug Market Size by Regions

• 4.1 Global Ophthalmology Disorders Drug Revenue and Market Share by Regions
• 4.2 North America Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 4.3 Europe Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 4.5 South America Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)

5 North America Ophthalmology Disorders Drug Revenue by Countries

• 5.1 North America Ophthalmology Disorders Drug Revenue by Countries (2014-2019)
• 5.2 USA Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 5.3 Canada Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)

6 Europe Ophthalmology Disorders Drug Revenue by Countries

• 6.1 Europe Ophthalmology Disorders Drug Revenue by Countries (2014-2019)
• 6.2 Germany Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 6.3 UK Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 6.4 France Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 6.5 Russia Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 6.6 Italy Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Ophthalmology Disorders Drug Revenue by Countries

• 7.1 Asia-Pacific Ophthalmology Disorders Drug Revenue by Countries (2014-2019)
• 7.2 China Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 7.3 Japan Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 7.4 Korea Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 7.5 India Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)

8 South America Ophthalmology Disorders Drug Revenue by Countries

• 8.1 South America Ophthalmology Disorders Drug Revenue by Countries (2014-2019)
• 8.2 Brazil Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Ophthalmology Disorders Drug by Countries

• 9.1 Middle East and Africa Ophthalmology Disorders Drug Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 9.3 UAE Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Ophthalmology Disorders Drug Revenue and Growth Rate (2014-2019)

10 Global Ophthalmology Disorders Drug Market Segment by Type

• 10.1 Global Ophthalmology Disorders Drug Revenue and Market Share by Type (2014-2019)
• 10.2 Global Ophthalmology Disorders Drug Market Forecast by Type (2019-2024)
• 10.3 Oral Revenue Growth Rate (2014-2024)
• 10.4 Injection Revenue Growth Rate (2014-2024)
• 10.5 External Use Revenue Growth Rate (2014-2024)

11 Global Ophthalmology Disorders Drug Market Segment by Application

• 11.1 Global Ophthalmology Disorders Drug Revenue Market Share by Application (2014-2019)
• 11.2 Ophthalmology Disorders Drug Market Forecast by Application (2019-2024)
• 11.3 Juvenile Macular Degeneration (Stargardt Disease) Revenue Growth (2014-2019)
• 11.4 Leber Congenital Amaurosis (LCA) Revenue Growth (2014-2019)
• 11.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth (2014-2019)
• 11.6 Usher Syndrome Revenue Growth (2014-2019)
• 11.7 Retinitis Pigmentosa (Retinitis) Revenue Growth (2014-2019)

12 Global Ophthalmology Disorders Drug Market Size Forecast (2019-2024)

• 12.1 Global Ophthalmology Disorders Drug Market Size Forecast (2019-2024)
• 12.2 Global Ophthalmology Disorders Drug Market Forecast by Regions (2019-2024)
• 12.3 North America Ophthalmology Disorders Drug Revenue Market Forecast (2019-2024)
• 12.4 Europe Ophthalmology Disorders Drug Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Ophthalmology Disorders Drug Revenue Market Forecast (2019-2024)
• 12.6 South America Ophthalmology Disorders Drug Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Ophthalmology Disorders Drug Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology